Clinical Trial Update: Interest of a Dose Decrease for Radiotherapy Associated With Chemotherapy for Treatment of Standard Risk Adult Medulloblastomas [Phase 2]

View source ↗

Summary

This document reports an update on a Phase 2 trial exploring reducing radiotherapy dose when combined with chemotherapy for standard-risk adult medulloblastoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Medulloblastoma

Snippet

Sponsor: Central Hospital, Nancy, France | Conditions: Medulloblastoma | Phase 2 | Status: UNKNOWN